- Recursion Pharmaceuticals soars 121% after Nvidia invests $50 million in the biotech for AI drug discovery Yahoo Finance
- RXRX Stock Launches Into Stratosphere On $50 Million Nvidia Investment Investor’s Business Daily
- Nvidia invests $50 million in biotech company Recursion for A.I. drug discovery CNBC
- Recursion CEO Chris Gibson: There’s real opportunity to leverage A.I. to speed up drug development CNBC Television
- The A.I. mania is so red hot that a small $50 million investment from Nvidia sent an obscure biotech firm’s shares up a record 78% Fortune
- View Full Coverage on Google News
Read original article here